Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

The annual football game at Sportsman's Park in the 1930s drew big crowds ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.